MB
Mandy Ballinger
Omico, Garvan Institute of Medical Research, The University of Sydney, Monash University, International Sarcoma Kindred Study
Research areas: Biochemistry, Genetics and Molecular Biology · Genetics · BRCA gene mutations in cancer · Cancer Genomics and Diagnostics · Sarcoma Diagnosis and Treatment
0000-0002-9706-0514
Employment
-
Omico Head of Cohorts2019 - Present
-
Garvan Institute of Medical Research Group Leader - Genetic Cancer Risk2016 - Present
-
International Sarcoma Kindred Study Global Co-ordinator2008 - Present
-
Peter MacCallum Cancer Centre Post-doctoral Research Fellow2008 - 2015
Education
-
University of Sydney Master of Genetic Counselling2016 - 2017
-
Monash University PhD, General Medicine? - 2006
-
Monash University Bachelor of Science, First class Honours? - 2002
-
Monash University Bachelor of Applied Science? - 2001
Projects & Funding
Projects & funding information is unavailable.
Publications (65)
- Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program Save
- A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma Save
- Data from A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma Save
- Supplementary Tables 1-3 from A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma Save
- Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results Save
- Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation Save
- POT1 clinical risk management is an open question Save
- From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views Save
- ASPiRATION: Australian Observational Cohort Study of Comprehensive Genomic Profiling in Metastatic Lung Cancer Tissue Save
- Increased frequency of CHEK2 germline pathogenic variants among individuals with dermatofibrosarcoma protuberans Save
- Heritable defects in telomere and mitotic function selectively predispose to sarcomas Save
- Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study Save
- Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results Save
- Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results. Save
- Fear of cancer recurrence in patients undergoing germline genome sequencing Save
- Streamlined use of protein structures in variant analysis Save
- Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology Save
- Advanced cancer patient preferences for receiving molecular profiling results Save
- Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling Save
- Who should access germline genome sequencing? A mixed methods study of patient views Save